We would like to inform you today that BÜHLMANN Laboratories AG now has the fastest SARS-CoV-2 Antigen (Ag) rapid test on the market in its portfolio, which has just been validated and approved by the BAG. The FREND™ COVID-19 Ag test from NanoEntek delivers a reliable result in just 3 minutes.
The FREND™ COVID-19 Ag Test is a fluorescence immunoassay for use with the FREND ™ POCT System. It is intended for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab samples.
With the help of the FREND™ system, the qualitative result is available within 3 minutes, faster than any other test on the Swiss market. This saves valuable time in the treatment / isolation of the patient, for the health staff or in places where a quick result is of great importance (e.g. at airports, at events, etc.). The extremely simple handling with only three steps is convincing with this test system (see flyer).
Another added value is the new FREND™ POCT system, which includes a laboratory information system / data management (up to 1,000 patient results can be saved). The data can also be collected and transferred automatically (using a LIS connection). With the help of this technology, the result can be traced back to a patient ID. This reduces the risk of mix-ups and enables a high sample throughput as well as a later verification of the test result compared to classic Ag quick tests. This guarantees simple data processing and transmission of the results (see flyer).
In the clinical evaluation, the test shows 94.12% PPA (Positive Percent Agreement) and 100.00% NPA (Negative Percent Agreement). 109 clinical samples (34 positive and 75 negative) were confirmed by RT-PCR. The test was successfully validated and is now number 34 on the BAG list. For the BAG validation, a total of 421 clinical samples were compared with RT-PCR (119 positive and 302 negative). The test showed 94.95% PPA (Positive Percent Agreement) and 100% NPA (Negative Percent Agreement).